Atlas Trials

A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer

Clinical trial NCT01915472 · WITHDRAWN

Trial details

NCT number
NCT01915472
Sponsor
Gilead Sciences
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2013-09-01
Primary completion
2015-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.